SHOULD I USE 2.5 MG OR 5 MG NEBULISED SALBUTAMOL IN ACUTE EXACERBATIONS OF COPD?

被引：0
|
作者：
Kusre, Sandeep Rahul [1 ]
机构：
[1] Royal Free Hosp, London NW3 2QG, England
来源：
EMERGENCY MEDICINE JOURNAL | 2010年 / 27卷 / 10期
关键词：
D O I：
10.1136/emj.2010.101311
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：789 / 790
页数：4
相关论文
共 50 条
  • [1] The role of nebulised budesonide in the treatment of acute exacerbations of COPD
    Gunen, H.
    Hacievliyagil, S. S.
    Yetkin, O.
    Gulbas, G.
    EUROPEAN RESPIRATORY JOURNAL, 2007, 30 (02) : 399 - 400
  • [2] Nexiam (R) 2.5 mg and 5 mg sachets
    不详
    SA PHARMACEUTICAL JOURNAL, 2015, 82 (02) : 30 - 31
  • [3] A comparison of preference for and efficacy of tablet formulations of sumatriptan (50 mg and 100 mg), naratriptan (2.5 mg), rizatriptan (10 mg), and zolmitriptan (2.5 mg) in the acute treatment of migraine
    Carl Dahlöf
    Martin Jones
    Kim Davis
    Jane Loftus
    Reijo Salonen
    The Journal of Headache and Pain, 2004, 5 (2) : 115 - 122
  • [4] Antibiotherapy of acute exacerbations of COPD: should we accept incertitude?
    Buisson, CB
    REVUE DES MALADIES RESPIRATOIRES, 2004, 21 (02) : 241 - 244
  • [5] Use of nebulised magnesium sulphate as an adjuvant in the treatment of acute exacerbations of COPD in adults: a randomised double-blind placebo-controlled trial
    Edwards, Llifon
    Shirtcliffe, Philippa
    Wadsworth, Kirsten
    Healy, Bridget
    Jefferies, Sarah
    Weatherall, Mark
    Beasley, Richard
    THORAX, 2013, 68 (04) : 338 - 343
  • [6] Mifepristone 2.5 mg versus 5 mg daily in the treatment of leiomyoma before surgery
    Carbonell Esteve, Josep L.
    Riveron, Ana M.
    Cano, Mariela
    Ortiz, Alma I.
    Valle, Aleta
    Texido, Carlos S.
    Tomasi, Giuseppe
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2012, 4 : 75 - 84
  • [7] Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine
    Pascual, J
    Vega, P
    Diener, HC
    Allen, C
    Vrijens, F
    Patel, K
    CEPHALALGIA, 2000, 20 (05) : 455 - 461
  • [8] Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
    Sadatsafavi, Mohsen
    McCormack, James
    Petkau, John
    Lynd, Larry D.
    Lee, Tae Yoon
    Sin, Don D.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (02)
  • [9] ANTIBIOTIC AND CORTICOSTEROID DRUG USE EVALUATION FOR COPD ACUTE EXACERBATIONS
    Jong, T.
    Megram, E.
    Packer, B.
    Seah, E.
    Tan, S.
    Kentwell, S.
    Wah, K.
    Masel, P.
    Reid, D.
    RESPIROLOGY, 2021, 26 : 147 - 147
  • [10] 5 versus 14 days of prednisone for acute COPD exacerbations
    Quint, Laura J.
    THORAX, 2014, 69 (09)
12345